Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (Review)

Al-Attar, 2006, Keloid pathogenesis and treatment, Plast Reconstr Surg, 117, 286, 10.1097/01.prs.0000195073.73580.46

Atiyeh, 2005, Keloid or hypertrophic scar: the controversy: review of the literature, Ann Plast Surg, 54, 676, 10.1097/01.sap.0000164538.72375.93

Estrem, 1987, Implantation of human keloid into athymic mice, Laryngoscope, 97, 1214, 10.1288/00005537-198710000-00018

Pierce, 1979, Keloids: enigma of the plastic surgeon, J Natl Med Assoc, 71, 1177

Huang, 2012, Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings, Int Wound J

de Mesquita, 2010, About strawberry, crab claws, and the Sir James Black’s invention. Hypothesis: can we battle keloids with propranolol?, Med Hypotheses, 74, 353, 10.1016/j.mehy.2009.08.035

Akaishi, 2008, Keloid and hypertrophic scar: neurogenic inflammation hypotheses, Med Hypotheses, 71, 32, 10.1016/j.mehy.2008.01.032

Alonso, 2008, Keloids: A viral hypothesis, Med Hypotheses, 70, 156, 10.1016/j.mehy.2007.03.023

O’Brien, 2013, Silicone gel sheeting for preventing and treating hypertrophic and keloid scars, Cochrane Database Syst Rev, 9, 10.1002/14651858.CD003826.pub3

Kischer, 1982, Hypertrophic scars and keloids: a review and new concept concerning their origin, Scan Electron Microsc, 4, 1699

Tredget, 1997, Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy, Surg Clin North Am, 77, 701, 10.1016/S0039-6109(05)70576-4

Sandulache, 2007, Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta 1-induced collagen synthesis, Wound Repair Regen, 15, 122, 10.1111/j.1524-475X.2006.00193.x

Clark, 1985, Cutaneous tissue repair: basic biologic considerations, I J Am Acad Dermatol, 13, 701, 10.1016/S0190-9622(85)70213-7

Sahl, 1994, Cutaneous scars: Part I, Int J Dermatol, 33, 681, 10.1111/j.1365-4362.1994.tb01511.x

Nakaoka, 1995, Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars, Acta Derm Venereol, 75, 102, 10.2340/0001555575102104

Nedelec, 2001, Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-alpha2b, Surgery, 130, 798, 10.1067/msy.2001.116453

Marneros, 2004, Keloids - clinical diagnosis, pathogenesis, and treatment options, J Dtsch Dermatol Ges, 2, 905, 10.1046/j.1439-0353.2004.04077.x

Ladin, 1998, p53 and apoptosis alterations in keloids and keloid fibroblasts, Wound Repair Regen, 6, 28, 10.1046/j.1524-475X.1998.60106.x

Messadi, 1998, Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts, Front Biosci, 3, a16, 10.2741/A246

Sayah, 1999, Downregulation of apoptosis-related genes in keloid tissues, J Surg Res, 87, 209, 10.1006/jsre.1999.5761

Fujiwara, 2005, Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration, Br J Dermatol, 153, 295, 10.1111/j.1365-2133.2005.06698.x

Calderon, 1996, Increased proliferation in keloid fibroblasts wounded in vitro, J Surg Res, 61, 343, 10.1006/jsre.1996.0127

Moon, 2008, Isolation and characterization of multipotent human keloid-derived mesenchymal-like stem cells, Stem Cells Dev, 17, 713, 10.1089/scd.2007.0210

Chen, 2003, Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray, J Surg Res, 113, 208, 10.1016/S0022-4804(03)00188-4

Messadi, 2004, Activation of NFkappaB signal pathways in keloid fibroblasts, Arch Dermatol Res, 296, 125, 10.1007/s00403-004-0487-y

Tosa, 2005, Global gene expression analysis of keloid fibroblasts in response to electron beam irradiation reveals the involvement of interleukin-6 pathway, J Invest Dermatol, 124, 704, 10.1111/j.0022-202X.2005.23592.x

Ehrlich, 1994, Morphological and immunochemical differences between keloid and hypertrophic scar, Am J Pathol, 145, 105

Szulgit, 2002, Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars, J Invest Dermatol, 118, 409, 10.1046/j.0022-202x.2001.01680.x

Alster, 2003, Hypertrophic scars and keloids: etiology and management, Am J Clin Dermatol, 4, 235, 10.2165/00128071-200304040-00003

Tuan, 1998, The molecular basis of keloid and hypertrophic scar formation, Mol Med Today, 4, 19, 10.1016/S1357-4310(97)80541-2

Zhang, 2006, Hypoxia-induced HIF-1 alpha accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt, Exp Cell Res, 312, 145, 10.1016/j.yexcr.2005.10.006

Harty, 2003, Regeneration or scarring: an immunologic perspective, Dev Dyn, 226, 268, 10.1002/dvdy.10239

Makino, 2008, DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts, J Dermatol Sci, 51, 171, 10.1016/j.jdermsci.2008.03.003

De Bosscher, 1997, Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation, Proc Natl Acad Sci USA, 94, 13504, 10.1073/pnas.94.25.13504

Yin, 1998, The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β, Nature, 396, 77, 10.1038/23948

Gilmore, 2006, Inhibitors of NF-kappaB signaling: 785 and counting, Oncogene, 25, 6887, 10.1038/sj.onc.1209982